Journal Scans
Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era
Rituximab for Post-transplantation Lymphoproliferative Disorder
AM Evens, KA David, I Helenowski, B Nelson, D Kaufman, SM Kircher, A Gimelfarb, E Hattersley, LA Mauro, B Jovanovic, A Chadburn, P Stiff, JN Winter, J Mehta, K Van Besien, S Gregory, LI Gordon, JM Shammo, SE Smith, SM Smith
20100019
2010 Jan 19
J Clin Oncol
Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era
J Clin Oncol. 2010 Jan 19;[Epub Ahead of Print], AM Evens, KA David, I Helenowski, B Nelson, D Kaufman, SM Kircher, A Gimelfarb, E Hattersley, LA Mauro, B Jovanovic, A Chadburn, P Stiff, JN Winter, J Mehta, K Van Besien, S Gregory, LI Gordon, JM Shammo, SE Smith, SM Smith
ABSTRACT
In this multicenter, retrospective analysis of 80 patients with post-transplant lymphoproliferative disorder (PTLD), addition of rituximab to first-line therapy with reduction of immunosuppression was...
